Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$517K Buy
1,001,912
+989,922
+8,256% +$592K 0.03% 983
2026
Q1
$8K Sell
11,990
-329,283
-96% -$248K ﹤0.01% 1658
2025
Q4
$300K Buy
341,273
+23,528
+7% +$25.1K 0.03% 1170
2025
Q3
$432K Buy
317,745
+90,571
+40% +$137K 0.04% 954
2025
Q2
$357K Buy
+227,174
New +$423K 0.03% 1157
2024
Q4
Sell
-445,805
Closed -$1.48M 1688
2024
Q3
$1.48M Buy
445,805
+73,456
+20% +$250K 0.11% 223
2024
Q2
$1.15M Buy
372,349
+328,837
+756% +$1.08M 0.08% 415
2024
Q1
$176K Buy
+43,512
New +$164K 0.01% 1428

Other funds holding DCGO

GSA Capital Partners's DCGO Position: Q2 2026 in Review

GSA Capital Partners increased its DocGo (DCGO) stake by 8,256% in Q2 2026, buying an estimated $592K and bringing the position to 1,001,912 shares worth $517K. The position accounts for 0.03% of the portfolio, ranked #983.

GSA Capital Partners first reported a position in DCGO in Q1 2024 and has held it in 8 quarters since. The position peaked at $1.48M in Q3 2024. 119 funds tracked by Wall St. Rank hold DCGO as of Q2 2026.

  • GSA Capital Partners held 1,001,912 shares of DocGo worth $517K as of Q2 2026.
  • GSA Capital Partners bought 989,922 DocGo shares in Q2 2026, an estimated $592K.
  • DocGo made up 0.03% of GSA Capital Partners's portfolio in Q2 2026, its #983 holding.
  • GSA Capital Partners first reported a position in DocGo in Q1 2024 and has held it in 8 quarters since.
  • GSA Capital Partners's DocGo position peaked at $1.48M in Q3 2024.
  • 119 funds tracked by Wall St. Rank held DocGo as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.